Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies
In recent years, evidence has accumulated that cannabinoids—especially the non-psychoactive compound, cannabidiol (CBD)—possess promising medical and pharmacological activities that might qualify them as potential anti-tumor drugs. This review is based on multiple studies summarizing different mecha...
Main Authors: | Fei Wang, Gabriele Multhoff |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/4/582 |
Similar Items
-
Cannabidiol (CBD) as a Promising Anti-Cancer Drug
by: Emily S. Seltzer, et al.
Published: (2020-10-01) -
Pharmacokinetics of cannabidiol-/cannabidiolic acid-rich hemp oil in juvenile cynomolgus macaques (Macaca fascicularis)
by: Tinika N. Johns, et al.
Published: (2023-11-01) -
Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
by: Christopher S. Pauli, et al.
Published: (2020-02-01) -
The therapeutic potential of purified cannabidiol
by: Saoirse Elizabeth O’Sullivan, et al.
Published: (2023-06-01) -
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke
by: Michihiro Fujiwara, et al.
Published: (2010-07-01)